An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models

10.1021/acsbiomaterials.2c00202

Saved in:

Bibliographic Details
Main Authors:	Chua, Koon Jiew, Ling, Hua, Hwang, In Young, Lee, Hui Ling, March, John C, Lee, Yung Seng, Chang, Matthew Wook
Other Authors:	PAEDIATRICS
Format:	Article
Language:	English
Published:	AMER CHEMICAL SOC 2023
Subjects:	probiotics E. coli Nissle interferon anti-inflammation inflammatory bowel diseases
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/239198
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-239198
record_format	dspace
spelling	sg-nus-scholar.10635-2391982024-11-15T07:40:33Z An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models Chua, Koon Jiew Ling, Hua Hwang, In Young Lee, Hui Ling March, John C Lee, Yung Seng Chang, Matthew Wook PAEDIATRICS BIOCHEMISTRY Dr Koon Jiew Chua probiotics E. coli Nissle interferon anti-inflammation inflammatory bowel diseases 10.1021/acsbiomaterials.2c00202 ACS BIOMATERIALS SCIENCE & ENGINEERING 2023-05-04T09:56:53Z 2023-05-04T09:56:53Z 2022-11-18 2023-05-04T07:55:06Z Article Chua, Koon Jiew, Ling, Hua, Hwang, In Young, Lee, Hui Ling, March, John C, Lee, Yung Seng, Chang, Matthew Wook (2022-11-18). An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models. ACS BIOMATERIALS SCIENCE & ENGINEERING. ScholarBank@NUS Repository. https://doi.org/10.1021/acsbiomaterials.2c00202 2373-9878 https://scholarbank.nus.edu.sg/handle/10635/239198 en AMER CHEMICAL SOC Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	probiotics E. coli Nissle interferon anti-inflammation inflammatory bowel diseases
spellingShingle	probiotics E. coli Nissle interferon anti-inflammation inflammatory bowel diseases Chua, Koon Jiew Ling, Hua Hwang, In Young Lee, Hui Ling March, John C Lee, Yung Seng Chang, Matthew Wook An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
description	10.1021/acsbiomaterials.2c00202
author2	PAEDIATRICS
author_facet	PAEDIATRICS Chua, Koon Jiew Ling, Hua Hwang, In Young Lee, Hui Ling March, John C Lee, Yung Seng Chang, Matthew Wook
format	Article
author	Chua, Koon Jiew Ling, Hua Hwang, In Young Lee, Hui Ling March, John C Lee, Yung Seng Chang, Matthew Wook
author_sort	Chua, Koon Jiew
title	An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
title_short	An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
title_full	An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
title_fullStr	An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
title_full_unstemmed	An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
title_sort	engineered probiotic produces a type iii interferon ifnl1 and reduces inflammations in in vitro inflammatory bowel disease models
publisher	AMER CHEMICAL SOC
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/239198
_version_	1821199510285582336

An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models

Similar Items